The State of AI Regulation in Healthcare: Still Complicated
This August 2026 health law analysis describes the evolving regulatory landscape for AI in healthcare, emphasizing that FDA continues to prioritize premarket review for higher‑risk clinical systems such as AI‑assisted radiology and pathology tools. The article highlights January 2026 guidance on clinical decision support software, which clarifies that AI products directly influencing clinical judgment or patient management will likely require FDA review or clearance, underscoring ongoing governance challenges.
About LOG Standards
LOG Standards provides an independent accreditation signal for AI models used in healthcare, helping hospitals, care networks, and AI companies bring clinical AI readiness and governance into clearer conversations.
Our AI Intelligence Briefing tracks the latest developments in AI safety, AI in medicine, mental health AI, clinical AI governance, and regulatory policy — keeping healthcare stakeholders informed about the rapidly evolving AI landscape.